{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-25-000003","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.932293+00:00","generated_at":"2026-05-28T01:41:58.773220+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Charles River Labs provides preliminary 2025 outlook: revenue decline, CDMO client losses, potential impairment","bullets":["Expects 2025 revenue to decline organically in similar range as estimated 2024; DSA demand consistent with H2 2024.","CDMO revenue headwind: a cell therapy client terminated commercial agreement; lower revenue from another cell therapy client; ~1% consolidated revenue growth drag.","Site consolidation actions (~0.5%) and FX (>1%) also expected to reduce reported revenue in 2025.","Non-GAAP operating margin expected modestly below estimated 2024 level; cost savings cannot fully offset lower revenue.","Assessing recoverability of goodwill and long-lived assets for potential impairment due to CDMO business challenges."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-25-000003","json":"https://secwatch.observer/filing/0001100682-25-000003.json","markdown":"https://secwatch.observer/filing/0001100682-25-000003.md","text":"https://secwatch.observer/filing/0001100682-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068225000003/0001100682-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068225000003/crl-20250114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:41:58.773220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}